News | Heart Failure | February 22, 2017

New RightSTEPS Educational Initiative to Drive Change in Clinician Prescribing Behavior for Chronic Heart Failure

Blended-learning initiative provides comprehensive education to empower clinicians to take the RightSTEPS to treat the right patients with the right drugs at the right dose at the right time

ACC, Haymarket Medical Education, HME, myCME, RightSTEPS initiative, prescribing behavior, chronic heart failure

February 22, 2017 — The American College of Cardiology (ACC), Haymarket Medical Education (HME) and myCME have joined forces to develop RightSTEPS: Optimizing Medical Therapy for Chronic Heart Failure. This long-term education initiative aims to help clinicians follow prescribing guidelines to reduce hospitalizations and readmissions and to improve patient outcomes to address the 75 percent of chronic heart failure (HF) patients who do not receive optimal doses of guideline-recommended drugs.

Launching in 2017, with additional education to be added regularly throughout the year, the program is overseen by leading experts in HF treatment, including Akshay S. Desai, M.D., MPH, FACC, director, heart failure disease management, Cardiovascular Division, Brigham and Women’s Hospital and associate professor of ,edicine, Harvard Medical School. The curriculum includes American College of Cardiology/American Heart Association guideline-driven medical therapy, and it enables clinicians to:

  • Learn via a dedicated online Cardiology Learning Center on myCME offering self-paced, personalized educational activities that are eligible for up to 16 continuing medical education (CME)/continuing nursing education (CNE) complimentary credits, including individualized treatments for various gender and racial/ethnic populations;
  • Practice during face-to-face live meetings at regional healthcare systems, with parallel sessions for patients and caregivers at Veterans Affairs hospitals; and
  • Perform and receive customized online coaching that qualifies as a Centers for Medicare & Medicaid Services (CMS) Quality Payment Program Improvement Activity under the new Merit-based Incentive Payment System (MIPS).

“Improving heart health is at the core of the ACC’s mission,” said Desai, ACC RightSTEPS chair and course director. “With RightSTEPS, medical professionals treating heart failure patients have easier access to the tools they need to make informed, guideline-driven decisions and provide their patients with the highest quality care.”

“Successful treatment of chronic HF depends on both medical knowledge and ongoing dialogue,” said Priya Wanchoo, M.D., medical director of myCME. “We’re pleased the education we develop with the ACC for RightSTEPS will have a dedicated home on myCME. We believe it will provide clinicians a support center for their efforts in providing optimal patient care.”

Supported by an independent educational grant from Novartis Pharmaceuticals Corporation, the curriculum is designed for the range of clinicians who provide care for patients with chronic HF, including cardiologists, internists, primary care physicians, nurses, nurse practitioners and physician assistants. To further close the circle and improve performance, it includes education geared for patients with chronic HF and their caregivers.

For more information: www.mycme.com/rightsteps

Related Content

New Target for Treating Heart Failure Identified by Penn Medicine Researchers

Microtubules in heart cells from a healthy patient (left) and from a patient with heart failure. The dense network of detyrosinated microtubules impedes the motion of the failing heart cell during the heart beat. Credit: Ben Prosser lab, Perelman School of Medicine, University of Pennsylvania

News | Heart Failure | June 25, 2018
New research finds changes in cellular struts called microtubules (MT) can affect the stiffness of diseased human heart...
Gencaro Does Not Reduce Atrial Fibrillation Risk in Heart Failure Patients
News | Heart Failure | May 30, 2018
Data from the GENETIC-AF trial was presented in a “Late Breaking Clinical Trials” oral presentation at the European...
Cardiac Contractility Modulation Safe and Effective as Heart Failure Treatment

Image courtesy of Impulse Dynamics

News | Heart Failure | May 18, 2018
In a new study, cardiac contractility modulation (CCM) therapy was confirmed to significantly improve exercise...
V-Wave Closes $70M Financing to Support Pivotal Study of Heart Failure Therapy
News | Heart Failure | May 16, 2018
Israel-based V-Wave Ltd. recently closed a $70 million Series C financing for its proprietary, minimally invasive...
News | Heart Failure | May 14, 2018
Ancora Heart Inc. announced the expansion of the company’s U.S. feasibility study to evaluate the investigational...
Protein Clumping May Contribute to Heart Failure Development

A PET scan detects clumping proteins in rat hearts (top). The enlarged heart (right) is one with heart failure. Other PET scans showing blood flow in the rat hearts (bottom) show that the protein clumps aren't due to circulation problems. Image courtesy of Circulation Research, May 11, 2018.

News | Heart Failure | May 11, 2018
A team led by Johns Hopkins University Researchers has discovered that protein clumps appear to accumulate in the...
Minnesota Living With Heart Failure Questionnaire Qualified for FDA Medical Device Development Tools Program

The CORolla device from Israel-based CorAssist is one example of new devices being manufactured and tested to treat heart failure. The efficacy of this and other new devices under development can now be assessed with the Minnesota Living With Heart Failure Questionnaire. 

Technology | Heart Failure | May 07, 2018
The U.S. Food and Drug Administration (FDA) has qualified the Minnesota Living with Heart Failure Questionnaire from...
Nation's First Heart Failure and Arrhythmia Center Opening in Ohio

Image courtesy of The Ohio State University

News | Heart Failure | April 04, 2018
The Ohio State University Wexner Medical Center will establish the nation’s first center dedicated to treating those...
Abbott Initiates GUIDE-HF Trial for Improved Outcomes With CardioMEMS Monitor
News | Heart Failure | March 29, 2018
Abbott announced the company has initiated the landmark GUIDE-HF clinical trial using the CardioMEMS HF System. The...
Overlay Init